Letter regarding “Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase”

Letter regarding “Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase”

Bibliographic Details
Main Authors:	Chia-Ming Chu, Yun-Fan Liaw
Format:	Article
Language:	English
Published:	Korean Association for the Study of the Liver 2023-04-01
Series:	Clinical and Molecular Hepatology
Subjects:	chronic hepatitis b immune tolerance age alanine aminotransferase hepatitis b virus
Online Access:	http://e-cmh.org/upload/pdf/cmh-2023-0018.pdf

Similar Items

Letter regarding “Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?”
by: Halil Haldun Emiroglu
Published: (2023-07-01)

Correspondence on Letter regarding “Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune tolerant phase”
by: Jeong-Ju Yoo, et al.
Published: (2023-04-01)

Is alanine aminotransferase flare-up in nucleos(t)ide analogue treatment of chronic hepatitis B a promising, rather than a devastating, sign?
by: Nae-Yun Heo
Published: (2017-06-01)

A noninvasive model discriminating significant histological changes in treatment-naive chronic hepatitis B patients with normal ALT
by: Jiaming Teng, et al.
Published: (2023-01-01)

Off-treatment efficacy of 3-year nucleos(t)ide analogues in chronic hepatitis B patients
by: Ching-Chung Lin, et al.
Published: (2016-01-01)

Seroprevalence of canine hepatitis in stray dogs in Nineveh Province, Iraq
by: Zahraa Mustafa Al-Jumaa, et al.
Published: (2020-11-01)

TREAT-B Algorithm for Treatment Eligibility Among Chronically Infected Hepatitis B Virus Persons in a Low and a High Endemic Region: A Potential Strategy Towards Virus Elimination by 2030
by: Hussein Mukasa Kafeero, et al.
Published: (2022-04-01)

Development and Validation of a Nomogram to Predict Significant Liver Inflammation in Patients with Chronic Hepatitis B
by: Jiang S, et al.
Published: (2023-08-01)

Hepatitis B and C prevalences among blood donors in the south region of Brazil
by: H. C. F. F. Vasconcelos, et al.
Published: (1994-12-01)

Epidemiology and outcomes of marked elevations of alanine aminotransferase >1000 IU/L in an Australian cohort
by: Danny Con, et al.
Published: (2020-04-01)

Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase
by: Jeong-Ju Yoo, et al.
Published: (2023-04-01)

Hepatitis B Virus Treatment and Hepatocellular Carcinoma: Controversies and Approaches to Consensus
by: Soo Ki Kim, et al.
Published: (2022-08-01)

Effectiveness of antiviral treatment in HBeAg-negative chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase: a retrospective study
by: Sufang Wei, et al.
Published: (2022-08-01)

Hepatitis C and hepatitis B virus infection in different hemodialysis units in Belo Horizonte, Minas Gerais, Brazil
by: Busek Solange U, et al.
Published: (2002-01-01)

Long-term trends of alanine aminotransferase levels among persons living with human immunodeficiency virus/hepatitis B virus with and without hepatitis delta coinfection
by: Lorin Begré, et al.
Published: (2022-09-01)

A Non-invasive Model for Predicting Liver Inflammation in Chronic Hepatitis B Patients With Normal Serum Alanine Aminotransferase Levels
by: Xiaoke Li, et al.
Published: (2021-06-01)

Serological Features of Children Vertically Infected With Hepatitis B Virus: A Study in Amir Al-Momenin Ali Hospital of Zabol
by: Iraj Shahramian, et al.
Published: (2021-03-01)

Antiviral Therapy for Chronic HBV Infection With Persistently Normal Alanine Aminotransferase: Controversy and Consensus
by: Jing Zhou, et al.
Published: (2021-08-01)

Association of Alanine Aminotransferase Levels (ALT) with the Hepatic Insulin Resistance Index (HIRI): a cross-sectional study
by: Gómez-Sámano Miguel, et al.
Published: (2012-09-01)

Seroprevalence of hepatitis B virus co-infection among HIV-1-positive patients in North-Central Nigeria: The urgent need for surveillance
by: Terver M. Akindigh, et al.
Published: (2019-06-01)

Prevalence of chronic hepatitis B phases in Eritrean patients: a laboratory-based cross-sectional study
by: Mohammed Elfatih Hamida, et al.
Published: (2021-05-01)

Liver inflammation activity in patients with autoimmune hepatitis with normal alanine aminotransferase and immunoglobulin G levels
by: Yun Chen, et al.
Published: (2024-06-01)

Epstein Barr Virus Hepatitis—A Mild Clinical Symptom or a Threat?
by: Magdalena Rutkowska, et al.
Published: (2023-06-01)

Effective Analysis of Antiviral Treatment in Patients with HBeAg-Seropositive Chronic Hepatitis B with ALT < 2 Upper Limits of Normal: A Multi-center Retrospective Cohort Study
by: Meixin Hu, et al.
Published: (2023-01-01)

Viral hepatitis in patients infected with human immunodeficiency virus
by: Maria Helena P. Pavan, et al.

Viral hepatitis in patients infected with human immunodeficiency virus
by: Pavan Maria Helena P., et al.
Published: (2003-01-01)

Immunological measurement of aspartate/alanine aminotransferase in predicting liver fibrosis and inflammation
by: Hyun Jeong Kim, et al.
Published: (2020-03-01)

Current characteristics of chronic hepatitis B in Egypt
by: Maha M Elsabaawy, et al.
Published: (2019-01-01)

ALT Flare Predicts Hepatocellular Carcinoma Among Antiviral Treated Patients With Chronic Hepatitis B: A Cross-Country Cohort Study
by: Yanan Du, et al.
Published: (2021-01-01)

Changes in the prevalence of hepatitis B and metabolic abnormalities among young men in Korea
by: Byeong Geun Song, et al.
Published: (2022-09-01)

Development and Validation of a Non-invasive Model to Predict Liver Histological Lesions in Chronic Hepatitis B Patients With Persistently Normal Alanine Aminotransferase and Detectable Viremia
by: Qiankun Hu, et al.
Published: (2022-07-01)

Correspondence on Letter regarding “Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?”
by: Joo Hyun Oh, et al.
Published: (2023-07-01)

Serología en hepatitis virales = Serology in viral hepatitis
by: Jaramillo Aristizábal, María Clara, et al.
Published: (2011-03-01)

Patients with chronic hepatitis B who have persistently normal alanine aminotransferase or aged < 30 years may exhibit significant histologic damage
by: Sufang Wei, et al.
Published: (2024-03-01)

Inhibition of Alanine and Aspartate Aminotransferases by B-Nitropropionic Acid
by: Hassan M.Y. Osman
Published: (2007-03-01)

Definition and Management of the Immune Tolerance Phase in Chronic Hepatitis B
by: Young Mi Hong, et al.
Published: (2022-04-01)

Serum alanine aminotransferase levels, hematocrit rate and body weight correlations before and after hemodialysis session
by: Edmundo Pessoa Lopes, et al.
Published: (2009-01-01)

Hepatitis C virus infection in Egyptian children with type 1 diabetes mellitus: A single center study
by: Hekma Saad Farghaly, et al.
Published: (2014-01-01)

Serum N-Glycan Markers for Diagnosing Significant Liver Fibrosis and Cirrhosis in Chronic Hepatitis B Patients with Normal Alanine Aminotransferase Levels
by: Lin Wang, et al.
Published: (2023-07-01)

Co-infections of hepatitis B patients with other hepatitis viruses and their serological, biological and prognostic markers
by: Hudu Abdullahi, Shuaibu
Published: (2017)